-
Abstract Number: 1996
Granulomatous Reactions in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Literature Review
-
Abstract Number: 1997
Features of interleukin-1 and interleukin-6 Inhibitor (IL-1i/IL-6i) Related Severe Delayed Adverse Reactions in Subjects with or Without Reaction-risk Associated HLA-DRB1*15
-
Abstract Number: 1998
Association Between Small Interfering RNA Therapy and Autoimmune Diseases: U.S. Prospective Cohort Study
-
Abstract Number: 1999
Effects of JAK Inhibitors on Subsets of the Innate Immune System
-
Abstract Number: 2000
Induction of Systemic Inflammatory Diseases with Dupilumab Therapy
-
Abstract Number: 2001
Complications and Treatment Use Associated with Long-term Oral Corticosteroid Therapy Among Patients with Dermatomyositis or Polymyositis
-
Abstract Number: 2002
Pain and Physical Function, but Not Fatigue, Track with Disease Activity in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
-
Abstract Number: 2003
Cumulative Incidence of Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis in Lung Cancer Patients with and Without Hip Osteoarthritis and Impacts on Survival
-
Abstract Number: 2004
Rheumatic Complications Post-CAR-T Cell Therapy. Experience of a Single Center
-
Abstract Number: 2005
Impact of Anti-drug Antibodies on the Efficacy of SEL-212 in Patients with Chronic Gout Refractory to Conventional Therapy
-
Abstract Number: 2006
Gout Flares After Stopping Anti-inflammatory Prophylaxis During the Early Phases of Urate-Lowering Therapy
-
Abstract Number: 2007
Relationship Between Gout Flare Burden and Patient-Reported Outcome Following Allopurinol Initiation
-
Abstract Number: 2008
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Dose of ABP-671 in Participants with Chronic Kidney Disease (CKD)
-
Abstract Number: 2009
Risk of Incident Gout and Cardiovascular Events Within 120 Days of Incident Gout with the Use of Insulin Glargine, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Veterans with Type 2 Diabetes
-
Abstract Number: 2010
The Influence of Treat-to-target Urate Lowering Therapy and Anti-inflammatory Prophylaxis on Circulating Measures of Inflammation in Gout
- « Previous Page
- 1
- …
- 133
- 134
- 135
- 136
- 137
- …
- 181
- Next Page »